Quarterly Result6 Aug 2026, 10:41 pm
Sai Life Sciences Declares Unaudited Financial Results for Q1 FY27
AI Summary
Sai Life Sciences Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved the standalone and consolidated results, which were reviewed by statutory auditors Deloitte Haskins & Sells LLP. The filing also noted the allotment of 506,782 equity shares due to employee stock option exercises. The company operates in the CRDMO segment.
Key Highlights
- Unaudited standalone and consolidated financial results declared for Q1 FY27.
- Board of Directors approved the financial results on August 06, 2026.
- Statutory auditors provided an unmodified conclusion on the limited review.
- 506,782 equity shares allotted upon exercise of employee stock options.
- Company operates in the CRDMO segment.
Price Impact
More from SAILIFE
More in Quarterly Result